02.04.2012 • News • Teva • Teva Pharmaceutical Industries • pharmaceutical industry

Teva Launches Generic High Blood Pressure Drugs

Teva Pharmaceutical Industries has launched U.S. sales of irbesartan and irbesartan-hydrochlorothiazide tablets, generic versions of Sanofi Aventis' high blood pressure treatments Avapro and Avalide tablets.

The brand products had annual sales of $464 million and $124 million in the United States, based on sales data from the IMS research firm.

Israel-based Teva, the world's largest maker of generic drugs, has been awarded a 180-day period of marketing exclusivity, the company said on Monday.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.